Press Releases

Featured Press Releases

Nevada Governor Joe Lombardo Named BIO’s Governor…

WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…

Learn more

BIO Supports PDUFA VIII Commitment Letter and…

Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…

Learn more

BIO Statement on Senate Reintroduction of the…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …

Learn more

BIO and LCFC Support New Mexico Governor's Vision to Address Climate Change Through Clean Fuel Standard

January 20, 2021

Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…

BIO Condemns Trump Administration's Last-ditch Effort To Strip Critical Medicare Part D Protections

January 20, 2021

In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…

BIO Congratulates President Biden and Vice President Harris on "Historic Inauguration"

January 20, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office: “On behalf of the Biotechnology…

Biotechnology’s Leading Trade Group Restructures for the Future

January 19, 2021

Washington, DC – The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…

BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency

January 16, 2021

President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…

Trump Administration Move to Issue RFS Waivers "Beyond Egregious"

January 12, 2021

Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…

BIO Releases Statement Concerning Future Political Giving

January 11, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions: "As of today BIO will be pausing our political giving so we can…

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…

BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol

January 6, 2021

Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…

Injunction Placed on Punitive and Political Maneuver by Administration

December 29, 2020

A judge in the United States District Court for the Northern District of California yesterday issued a preliminary injunction blocking the Administration’s “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B…